Search Results - "FEIL, Gerhard"

Refine Results
  1. 1
  2. 2

    In vitro Myogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells as a Potential Treatment for Urethral Sphincter Muscle Repair by Drost, Adriana C., Weng, Sibylle, Feil, Gerhard, Schäfer, Jochen, Baumann, Simon, Kanz, Lothar, Sievert, Karl-Dietrich, Stenzl, Arnulf, Möhle, Robert

    Published in Annals of the New York Academy of Sciences (01-09-2009)
    “…To explore a new treatment strategy for urinary incontinence, human bone marrow mesenchymal stem cells (MSC) of the first in vitro passage were exposed to…”
    Get full text
    Journal Article
  3. 3

    Cytotoxic Effects of Treosulfan on Prostate Cancer Cell Lines by FEYERABEND, Susan, FEIL, Gerhard, KRUG, Jutta, KASSEN, Annette, STENZL, Arnulf

    Published in Anticancer research (01-07-2007)
    “…Objective: Despite various therapeutical options in metastatic prostate cancer, the lack of a curative approach motivates further investigations. Treosulfan is…”
    Get full text
    Journal Article
  4. 4

    Significant alterations of serum cytokine levels in patients with Peyronie's disease by Zimmermann, Reinhold P, Feil, Gerhard, Bock, Conny, Hoeltl, Lorenz, Stenzl, Arnulf

    Published in International Brazilian journal of urology (01-08-2008)
    “…To determine the expression of the cytokines transforming growth factor-beta1 (TGF-beta1), interferon-gamma (IFN-gamma), interleukin-6 (IL-6), and tumor…”
    Get full text
    Journal Article
  5. 5

    Heterogeneity in Prostate Cancer: Prostate Specific Antigen (PSA) and DNA Cytophotometry by KRAUSE, F. Steffen, FEIL, Gerhard, BICHLER, Karl-Horst, SCHROTT, Karl M, AKCETIN, Ziya Y, ENGEHAUSEN, Dirk G

    Published in Anticancer research (01-05-2005)
    “…Background: The heterogeneity in prostate cancer is the reason for the difficult diagnosis and prognosis of this tumor. In this study, we looked for a…”
    Get full text
    Journal Article
  6. 6
  7. 7

    In Vitro Investigations of Tissue-Engineered Multilayered Urothelium Established from Bladder Washings by Nagele, Udo, Maurer, Sabine, Feil, Gerhard, Bock, Conny, Krug, Jutta, Sievert, Karl-Dietrich, Stenzl, Arnulf

    Published in European urology (01-12-2008)
    “…Abstract Objective Human urothelial cells (HUCs) are commonly isolated from native urothelium requiring open or endoscopic surgery. The aim of this study was…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines by Pesch, Beate, Nasterlack, Michael, Eberle, Friedhelm, Bonberg, Nadine, Taeger, Dirk, Leng, Gabriele, Feil, Gerhard, Johnen, Georg, Ickstadt, Katta, Kluckert, Mattias, Wellhäußer, Harald, Stenzl, Arnllf, Brüning, Thomas

    Published in BJU international (01-08-2011)
    “…Study Type – Diagnostic (validating cohort) Level of Evidence 1b What's known on the subject? and What does the study add? Microscopic haematuria (µH) is…”
    Get full text
    Journal Article
  10. 10

    From tissue engineering to regenerative medicine in urology — The potential and the pitfalls by Feil, Gerhard, Daum, Lisa, Amend, Bastian, Maurer, Sabine, Renninger, Markus, Vaegler, Martin, Seibold, Jörg, Stenzl, Arnulf, Sievert, Karl-Dietrich

    Published in Advanced drug delivery reviews (30-04-2011)
    “…Tissue engineering is a promising technique for the development of biological substitutes that can restore, maintain, or improve tissue function. The creation…”
    Get full text
    Journal Article
  11. 11

    Investigations of urothelial cells seeded on commercially available small intestine submucosa by FEIL, Gerhard, CHRIST-ADLER, Margot, MAURER, Sabine, CORVIN, Stefan, RENNEKAMPFF, Hans-Oliver, KRUG, Jutta, HENNENLOTTER, Jörg, KUEHS, Ursula, STENZL, Arnulf, SIEVERT, Karl-Dietrich

    Published in European urology (01-12-2006)
    “…To examine adherence and viability of human urothelial cells seeded on commercially available small intestine submucosa (SIS) specimens under serum-free…”
    Get full text
    Journal Article
  12. 12

    Clinical experience with survivin as a biomarker for urothelial bladder cancer by Horstmann, Marcus, Bontrup, Heike, Hennenlotter, Jörg, Taeger, Dirk, Weber, Anne, Pesch, Beate, Feil, Gerhard, Patschan, Oliver, Johnen, Georg, Stenzl, Arnulf, Brüning, Thomas

    Published in World journal of urology (01-06-2010)
    “…Objectives This study was carried out as a prospective pilot study to evaluate the potential of survivin mRNA measurement in patients suspicious for urothelial…”
    Get full text
    Journal Article
  13. 13

    Immunoreactivity of p63 in Monolayered and In Vitro Stratified Human Urothelial Cell Cultures Compared with Native Urothelial Tissue by Feil, Gerhard, Maurer, Sabine, Nagele, Udo, Krug, Jutta, Bock, Conny, Sievert, Karl-Dietrich, Stenzl, Arnulf

    Published in European urology (01-05-2008)
    “…Abstract Objective To investigate the immunoreactivity of p63 in monolayered and stratified human urothelial cell cultures and in normal urothelial tissues to…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Value of apoptin’s 40-amino-acid C-terminal fragment for the differentiation between human tumor and non-tumor cells by Heckl, Stefan, Regenbogen, Marc, Sturzu, Alexander, Gharabaghi, Alireza, Feil, Gerhard, Beck, Alexander, Echner, Hartmut, Nagele, Thomas

    Published in Apoptosis (London) (01-04-2008)
    “…Apoptin, a protein of the chicken anemia virus (CAV), consists of 121 amino acids (aa) and represents a novel, potentially tumor-specific therapeutic and…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Renal cell carcinoma: relevance of angiogenetic factors by Wechsel, H W, Bichler, K H, Feil, G, Loeser, W, Lahme, S, Petri, E

    Published in Anticancer research (01-03-1999)
    “…Angiogenesis is essential for tumour growth. Mostly hypervasculariced renal cell carcinoma (RCC) usually express angiogenic factors, e.g. basic fibroblast…”
    Get more information
    Journal Article
  19. 19

    Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder by Feil, Gerhard, Zumbrägel, Andreas, Päulgen-Nelde, Hans J, Hennenlotter, Jörg, Maurer, Sabine, Krause, Stefen, Bichler, Karl-Horst, Stenzl, Arnulf

    Published in Anticancer research (01-03-2003)
    “…The ImmunoCyt assay (Diagnocure Inc., Québec, Canada) is a new immunocytological fluorescence test for identifying two different mucins and a…”
    Get more information
    Journal Article
  20. 20

    Comparison of cytology and nuclear matrix protein 22 (NMP 22) for the detection and follow-up of bladder-cancer by Lahme, Sven, Bichler, Karl-Horst, Feil, Gerhard, Zumbrägel, Andreas, Götz, Tobias

    “…This study was designed to determine the clinical usefulness of the Nuclear Matrix Protein 22 (NMP 22) Test for the detection of bladder cancer in comparison…”
    Get more information
    Journal Article